Advances and challenges in hemophilic arthropathy
- 1 January 2016
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 53 (1) , 10-19
Abstract
No abstract availableKeywords
Funding Information
- National Hemophilia Foundation/Novo Nordisk Career Development Award
- Bayer Early Career Development Award (A.v.D.)
- National Institutes of Health (NHLBI) (HL104165 (L.O.M.))
This publication has 118 references indexed in Scilit:
- Value of biomarkers in osteoarthritis: current status and perspectivesAnnals of the Rheumatic Diseases, 2013
- Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970sBlood, 2013
- A single intra‐articular injection with IL‐4 plus IL‐10 ameliorates blood‐induced cartilage degeneration in haemophilic miceBritish Journal of Haematology, 2012
- Exploring the biological basis of haemophilic joint disease: experimental studiesHaemophilia, 2011
- Ultrasonography of haemophilic arthropathyHaemophilia, 2011
- Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritisJournal of Clinical Investigation, 2011
- Osteoarthritis year 2010 in review: biochemical markersOsteoarthritis and Cartilage, 2011
- Neoangiogenesis contributes to the development of hemophilic synovitisBlood, 2011
- Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockadeAnnals of the Rheumatic Diseases, 2010
- Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin αMβ2 binding motifJournal of Clinical Investigation, 2007